Table 2.

Antibiotic susceptibility testing interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria (2022) for patient 2

	P. aeruginosa
Amikacin	2 S
Cefepime	2 I
Ceftazidime	2 I
Ceftazidime/avibactam	2 S
Ceftolozane/tazobactam	1.5 S
Ciprofloxacin	>4 R
Colistin	2 S
Gentamicin	2 S
Imipenem	4 R
Meropenem	≤ 0.25 S
Meropenem (meningitis)	≤ 0.25 S
Piperacillin/tazobactam	≤ 4 I
Tobramycin	4 R

S, susceptible; I, susceptible, increased exposure; R, resistant.